WuXi Biologics is trading 4.22% up at HK$50.65, with no clear company-specific catalyst identified and possible positioning ahead of its August 25, 2026 board meeting.
- The August 24 decline was likewise reported without a direct catalyst.
- The board will review interim results for the six months ended June 30, 2026.